Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Needle therapy could speed relief for common hip pain condition

NCT ID NCT06529783

Symptom relief Sponsor: Universidad de Zaragoza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 15, 2026 · Updated 2 times

Summary

This pilot study tests whether a new technique called ultrasound-guided percutaneous neuromodulation can speed up recovery for people with chronic hip pain (GTPS). The treatment uses a tiny needle to stimulate a nerve near the hip, aiming to reduce pain and improve function faster than standard therapies like shockwave therapy and exercises. Fifty adults with long-lasting hip pain will receive either the new nerve treatment plus standard care, or standard care alone, and be followed for several months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ultrasound-guided percutaneous neuromodulation (needle-based nerve stimulation)
What this could lead to
If it works, this could offer a faster, non-surgical option to ease chronic hip pain and improve mobility for people with GTPS.
What could go wrong
This is a small pilot study with only 50 participants, so results may not apply to everyone. The technique is still experimental and may not prove better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

May 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Suffering from Greater Trochanteric Pain Syndrome (GTPS). * Experiencing local pain upon palpation of the greater trochanter area. * Having pain in the greater trochanter region lasting more than three months, indicating chronicity. * Being over 18 years of age. * Experiencing pain when bearing weight on the affected trochanter. * Having pain that impairs the functionality of resisted hip abduction. Exclusion Criteria: * Radiological evidence of pathology in the hip or knee joints. * Blood coagulation disorders. * Use of oral anticoagulants. * Presence of infections. * History of disc or hip surgery. * Presence of dysplasia, deformities, or sciatica. * History of vascular, neurological, or neoplastic diseases. * Specific contraindications for ultrasound-guided percutaneous neuromodulation (UG-PNM): belenophobia, pregnancy, pacemakers, epilepsy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Greater trochanteric pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Greater trochanteric pain syndrome

Contacts and locations

Locations

  • University of Zaragoza

    Zaragoza, Zaragoza, 50009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.